Snapshot from Jul 01, 2026 at 07:00 UTC. For live data and tracking: View Live
Business securities fraud investigation

Pomerantz Investigates Certara Securities Fraud

Analysis based on 14 articles · First reported May 21, 2026 · Last updated Jun 28, 2026

Sentiment
-60
Attention
4
Articles
14
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The market is impacted by the significant drop in Certara's stock price, reflecting investor concern over its financial performance and business decisions. The investigation by Pomerantz LLP could lead to further legal action and financial repercussions for Certara, potentially affecting its market valuation and investor confidence.

Legal Services Biotechnology

Pomerantz LLP is investigating Certara for potential securities fraud and unlawful business practices. This follows Certara's announcement of disappointing first-quarter 2026 financial results, including a 4% year-over-year decline in services revenue and a 14% decline in services bookings. The company also stated it would exit its regulatory business segment. These disclosures led to a 19% drop in Certara's stock price on May 11, 2026. The investigation aims to determine if Certara and its officers engaged in misconduct that harmed investors.

100 Pomerantz LLP investigating claims Certara
95 Certara saw stock price fall
90 Certara reported financial results
stock
Certara is the subject of a securities fraud investigation by Pomerantz LLP following a significant drop in its stock price after reporting disappointing Q1 2026 financial results and announcing an exit from its regulatory business.
Importance 100 Sentiment -70
priv
Pomerantz LLP is initiating an investigation into Certara for potential securities fraud and other unlawful business practices on behalf of investors.
Importance 80 Sentiment 50
per
Danielle Peyton is the contact person at Pomerantz LLP for investors interested in joining the class action investigation against Certara.
Importance 20 Sentiment 0
index
Nasdaq-100 is the stock exchange where Certara's shares are traded, and its stock price experienced a significant decline following the negative financial report.
Importance 10 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.